Bio/Pharmaceutical Analysis, ICP-MS

May 2nd 2021

Mass spectrometry and automation are growing in importance for protein characterization, but further improvements are still needed.

February 2nd 2021

Common approaches to analyze elemental impurities for compliance with regulatory requirements are robust but still have some limitations.

October 31st 2019

The company is expanding its bioanalytical capacity and capabilities to support biologic drug development, cell and gene therapy development, and biomarker analysis.

February 2nd 2019

Leveraging vast quantities of analytical data requires digitalization and platform integration.